Levodopa on Decrease of Plasma Taurine Level in Parkinsons

Levodopa on Decrease of Plasma Taurine Level in Parkinsons Title: Levodopa aggravates the decrease of plasma taurine level in Parkinson Disease Key words: Parkinson’s disease (PD); Oxidative stress; Levodopa; Toxicity; Taurine; Highlights: This is the first study to explore chronic use of levodopa on the change of plasma taurine level. Plasma taurine levels were significantly lower in both treated and untreated PD than in healthy controls. Much lower plasma taurine level was found in treated PD than the untreated. Plasma taurine level was negatively associated with cumulative dosage of levodopa in PD. Abbreviations: PD, Parkinson’s disease; MMSE, mini–mental state examination; DA, dopamine; ROS, reactive oxygen species; MAO, monoamine oxidase; CNS, central nervous system; H2O2, peroxide; SOD, superoxide dismutase; CSF, cerebrospinal fluid; Abstract In recent years, it has gained more and more focus that oxidative stress is implicated in the pathophysiology of Parkinson’s disease(PD) as well as the potential toxicity of levodopa to nigral cells. Also, an increasing body of evidence suggests that taurine plays an important role in anti-oxidant function. This study aimed to investigate the relationship between plasma taurine level and clinical variables and the cumulative dosage of levodopa in PD patients. 44 treated patients with PD (all receive levodopa), 68 untreated patients with PD and 96 age-and sex-matched healthy controls were recruited. Clinical data such as age, gender, duration, Hoehn and Yahr stage and medication history were collected. Approximate cumulative dosage of levodopa was calculated to indicate the toxicity of chronic intake of levodopa. Plasma levels of taurine were measured by HPLC-RF. Plasma taurine levels were significantly lower in both treated and untreated PD than healthy controls. Much lower pl asma taurine level was found in treated PD than the untreated. Furthermore, plasma taurine level was negatively associated with cumulative levodopa dosage in PD. Our preliminary study indicates that taurine may play an important role in pathophysiology of PD and toxicity of chronic levodopa treatment. Introduction PD is the second most common neurodegenerative disorder characterized by selectively loss of dopamine (DA)-containing neurons in the substantia nigra and a concomitant reduction of DA in the striatum. Levodopa, a natural precursor of DA, has been the‘gold standard’ therapy for PD patients for decades [1]. However, the  pathophysiology of PD is up to now still poorly understood. More and more focus comes to that oxidative stress is implicated in the pathophysiology of PD, manifested as protein oxidation, lipid peroxidation, DNA oxidation and so on [2]. Moreover, there has been an increasing concern that levodopa may be toxic to dopaminergic neurons [3-5], mainly because of its potential to autoxidize from a catechol to a quinine and to generate other forms of reactive oxygen species (ROS) [6]. Taurine, an endogenous amino acid (2-aminoethanesulfonic acid), is abundant in excitable tissues such as brain, retina, cardiac muscle and skeletal muscle [7]. Both in vitro and in vivo studies together demonstrate that the anti-oxidative activity of taurine is a vital avenue of cytoprotection [8-12]. Additionally, our previous study has reported that plasma taurine level was decreased in patients with PD [13]. Also, there are lines of evidence that taurine may exhibit cytoprotective effect by acting as a scavenger for harmful free radicals produced by DA or levodopa [14, 15]. However, the precise anti-oxidative mechanism of taurine involved in both PD pathophysiology and putative toxicity of levodopa still remains uncertain. Furthermore, few studies have been done to address the relationship between plasma taurine level and clinical variables as well as the toxic effects of chronic levodopa administration. Hence, in our study, we specifically explored the underlying impact on plasma taurine level because of long-term levodopa intake in PD patients. 2. Patients and methods 2.1 patients Patients with PD, diagnosed based on UK Parkinson’s disease Brain Bank criteria by two movement disorders specialists (Kezhong Zhang and Lian Zhang), were included in this study [16]. Clinical data were collected by the same medical worker and the Hoehn and Yahr stage was used to evaluate the severity of disease [17]. Since the anti-parkinsonian drugs may affect plasma taurine level, thorough medication histories were completely obtained through family and patient recall, personal medical chart, as well as computerized patient information system in our hospital. Exclusion criteria were atypical or secondary Parkinsonism, impaired cognitive status (assessed by the mini–mental state examination (MMSE) [18]), previous neurosurgical treatment for PD, significant laboratory, medical, or psychiatric abnormalities, or any condition that might affect plasma taurine level. Age -and gender-matched controls were also recruited, devoid of neurological disease, poor nutritional stat us, dementia or a family history of PD. The research project was approved by the ethics committee of the first affiliated hospital of Nanjing medical university and all the participants were given a full explanation and consented to the study in writing. 2.2 Calculation of the cumulative levodopa amount In order to assess the underlying toxicity of levodopa , an approximation of the cumulative levodopa amount was calculated based on the following equation (modified according to that ofNagatsuet al. [19]): cumulative levodopa amount [g] =daily amount of levodopa[mg] * duration of levodopa intake [month] *30 [d/month]*0.001[g/mg]. 2.3 Measurement of taurine levels from plasma Plasma taurine levels were measured as previously described [13]. 2.4 Statistical analysis All statistical analyses were performed in SPSSV.20.0 (SPSS, Chicago, IL, USA). The normality of the distribution of all continuous variables was examined by Shapiro–Wilk statistic. Homogeneity of variance was assessed by Levene’s test. Group comparisons were made using chi-square test for categorical variables, and one-way ANOVA as well as the Kruskal-Wallis test which was followed by the Mann-Whitney U test with Bonferroni correction for multiple comparisons (controls vs untreated patients, controls vstreated patients, untreated patients vs treated patients), as appropriate, for continuous variables. The correlation significance was evaluated by Spearman rank correlation coefficient.The statistical significance was set at P 3. Results 3.1. Demographic data, clinical variables and treatment status of PD Patients and Controls The demographic and clinical data of all subjects are summarized in Table 1. Gender and age did not differ among three groups, while the duration was longer (2.90 ±1.50vs. 1.45 ±1.14y, pHoehn and Yahr stage was higher (1.97 ±0.71vs. 1.67 ±0.72, pdetailed information on the treatment status see Table 2). 3.2. Plasma taurine level in PD patients and controls Notably, both treated PD (41.16 ±22.72 µmol/L) and untreated PD (57.38 ±31.05 µmol/L) were found to have significantly decreased plasma taurine levels compared to healthy controls (133.83 ±45.91 µmol/L, P for both comparisons for the two PD groups were considered as a whole, the mean taurine level was also significantly lower than that in the control group (P 3.3. Association between plasma taurine level and clinical variables and treatment status. Plasma taurine levels showed, however, no statistically significant association with age, duration, as well as Hoehn and Yahr stage in treated PD, untreated PD or all patients (Data not show). Interestingly, significant correlation was found between taurine level and cumulative levodopa dosage (shown in Fig.2, rs =-0.351, P Discussion According to our knowledge, this is the first study to explore chronic use of levodopa on the change of plasma taurine level. The major results of this study are summarized as follows: 1) Treated and untreated PD were found to have significantly decreased plasma taurine levels compared to healthy controls. 2) Plasma taurine level was lower in treated PD than the untreated, and inversely correlated with cumulative dosage of levodopa. Taurine, the most abundant amino acid in mammals, is widely distributed in central nervous system (CNS) [20] and its biosynthesis mainly takes place in the liver [21]. In the CNS, the concentration of taurine is dependent on food and a complex transport system at the blood brain barrier [20]. Hence, plasma taurine may partially reflect the pathological change in CNS of PD patients. Firstly, decreased plasma taurine level of patients with PD observed in this study is in line with our previous work [13]. Similarly, there have been some studies reporting CSF (cerebrospinal fluid) taurine level was significantly decreased in PD when compared to healthy controls [19, 22]. Previous studies provide evidence that taurine has a remarkable anti-oxidative function. Furthermore, in a study of PC12 cells, taurine exhibited a protective role against oxidative stress induced by peroxide (H2O2) through the alleviation of endoplasmic reticulum stress [12]. Also, Castro-Caldas et al. [10] reported that pretreatment of TUDCA (an analogue of taurine) abrogated the level of ROS in MPTP-mice, thus further highlighting the anti-oxidative role in vivo and suggesting that TUDCA may modulate the intracellular oxidative environment via interfering with the cellular redox threshold. Moreover, it has been observed that significant increases in glutathione content and superoxide dismutase ( SOD) activity were founded in the livers of the taurine-supplemented 6-OHDA–induced PD rats, which indicated that taurine may increase the defenses against oxidative insult [11]. Collectively, we assume that the decrease of plasma taurine level may result from chronic assumption of oxidants. Therefore, taurine may play an important neuroprotective role in the pathophysiology of PD via its potent anti-oxidative activity. By contrast, both normal [23] and increased [24-26] CSF taurine levels were found in several previous studies. Moreover, no significant decreased plasma taurine was observed in Molina et al.s study [22]. However, studies conductedby Lakke et al. [25, 26], Tohgi et al. [23] and Araki et al. [24] all had some limitations. For example, the controls were not well matched regarding gender and age. Additionally, different sample sizes and measurements may also partially explain the discrepancy of the results. Compared with those previous studies, we recruited relatively more patients in this study. Also, statistical analysis was well performed and measurement used in our study is more stable and sensitive. Nevertheless, we fail to observe correlation between plasma taurine level and age, duration and Hoehn and Yahr in treated PD, untreated PD or all PD. This may result from that only patients with relatively short duration (within 5 years) and low Hoehn and Yahr (within stage 3) were enrolled in our study, and the plasma taurine was probably not sensitive enough to examine the underlying correlation in early to medium stage PD patients. Therefore, further research including more stages of patients would bring more invaluable information on this point. Secondly, treated PD patients exhibited lower plasma taurine level than the untreated. Although the duration was longer and the Hoehn and Yahr stage was higher in treated PD than untreated PD, neither of the two clinical variables was correlated with plasma taurine level in each group. More importantly, plasma taurine level significantly negatively correlated with cumulative dosage of levodopa. These data suggest that chronic treatment of levodopa may affect plasma taurine concentration. Previous studies have shown that levodopa has the capacity to form ROS by autoxidation from catechols to quinines [4]. Interestingly, Biasetti et al. [27] found that taurine attenuated iron-catalyzed quinine formation from levodopa. Also, some studies suggest that taurine may bind these toxic quinones [27, 28]. Furthermore, there have been studies [29] showing that chronic systemic administration of levodopa to rodents depleted taurine pools, suggesting that taurine might play an important role in scavenging oxidants derived from levodopa metabolism in vivo. Therefore, we suppose that chronic consumption of taurine due to oxidants induced by levodopa may partially explain lower plasma taurine level in levodopa-treated PD than the untreated. However, there were different results observed in some other studies. Molina et al. [22] reported that no significant difference of CSF taurine level was found between levodopa-treated PD (n=21) and non-levedopa-treated PD (including untreated PD, n=8). The relatively small sample size may limit its interpretation. Moreover, Diederich et al. [30] found no significant decrease of plasma taurine after acute administration of levodopa. However, the acute levodopa administration may not fully refect the toxicity of cumulative levodopa intake. Nevertheless, our study has some limitations. Firstly, the population in this study is relatively small and the results must be interpreted cautiously. Secondly, as this is only a retrospective study, future longitudinal study combining with biomarkers of oxidative stress will provide more important information on the role of levodopa in affecting the plasma taurine level as a neurotixic agent and of taurine as a anti-oxidative agent. In conclusion, our results showed that decreased plasma taurine level was found in patients with PD in comparison to healthy controls. Moreover, plasma taurine level was found lowed in treated PD than the untreated, and inversely correlated with cumulative levodopa dosage. Combining with previous studies, these data suggest taurine may play an important protective role in pathophysiology of PD and chronic administration of levodopa may have potential neurotoxicity by depleting taurine. Also, our pilot study could, at least, provide new insights into therapeutic strategies.

Work Culture

* Career Interest Profiler, Competencies, and Work Culture Preferences * After completing the Career Interest Profiler, Competencies, and Work Culture Preferences activities I have a better understanding in how I will fit in and how my strengthens can help me be successful in my desired field of study. The Career Interest Profiler activity has determined a good career match would be; a credit analyst, auditor, risk management specialist, and an accountant.Possible degree options that would better fit these potential careers are Bachelor’s of Science in accounting, in business with a concentration in finance, and a Bachelor’s in Science in business with a concentration in global management just to name a few. The competencies activities have revealed my strengths are in Delivering Results, Following Instructions, Coping with Pressure, Organizing, Taking initiative, and finally adhering to Values.The Work Culture Preference activity has determined that my ideal work envir onment would have a very high work load, be a fast moving, demand goals and expectations of high performance, have career advancement, high salaries with rapid promotions and other benefits, career development, and the chance to learn new skills, career would be secure and stable, the company would focus on employment welfare, and have lots of personal development and feedback.A couple possible employers based, on my strengthens determined by the competence activity in relation to the job market research tool are McGladery, PriceWaterHouseCoopers, and Ernst & Young. McGladery, McGladrey LLP is the largest U. S. provider of assurance, tax and consulting services focused on the middle market, with nearly 6,500 professionals and associates in more than 75 offices nationwide.McGladrey is a licensed CPA firm. (www. mcgladery. com/about/about). PriceWatersHouseCoopers, PwC focuses on  audit and assurance,  tax  and  consulting services. Additionally, in the US, PwC concentrates on 16 key industries and provides targeted services that include — but are not limited to —  human resources,deals,  forensics, and  consulting services. We help resolve complex issues and identify opportunities. (www. pwc. om/us) All three of these employers are here in Tucson. McGladery in specific offers a few different internships in different seasons throughout the year, in different fields. These internships are offered to students that have 12-16 months left in obtaining there bachelor’s degree. After some research I believe a career in accounting, risk management, audit planning, and compliance would fit my Work Culture Preferences activity well.

Adult Learning Theory on Healthcare Organizations

Healthcare organizations need regular updates on their instructional designs on their employees and staff. This instructional designs or curriculums are much needed to inform the manpower of the organization on recent developments on technologies and applications on cases and situations, new regulations needed to be implemented or any other pertinent information for the organization’s and its staff’s needs to know.However, the method of educating the staff, whom majority are already on their adult stage, should be effective for them, and for the company. One applicable theory on educating the adult is Malcolm Knowles’ theory of andragogy.  It outlines effective methodologies for adult learning. On his theory, adults need to know why they should learn. On this case, the educator or administrator of the organization should make it a point that the staff understood the importance of the new information they should learn. Moreover, adults tend to ask when and where they will be able to use their new learning on real-life situations.Again, the educator should explain that the series of discussions to be made is for their self-improvement inside the organization towards the company’s goal and vision. Finally, adult learners should be well motivated on their new experience and learning. Incentives such as increased, self-esteem, job satisfaction and quality of life are significant in giving adults a basis to learn.  The various methodologies on adult learning and adult education are important for every educator. They should be also be knowledgeable on different approaches and techniques on educating an adult. Knowles’ theory is imperative for an educator developing an educational program so that we can address the consistent growing demands of adult education.ReferenceHolton, E. F., Swanson, D. A., & Knowles, M. S. (2005). The Adult Learner.Butterworth-Heinemann

My Philosophy Of Nursing Education - 770 Words

My philosophy of nursing education grows out of my philosophy of nursing. Much has been said related to healthcare reform, healthcare globalization, and healthcare delivery. A resounding theme in all of these discussions is the need for nurses to take a position of leadership in the healthcare industry (Institute of Medicine, 2010). I believe nurses, as leaders, are uniquely qualified to bridge the gap between the healthcare industry and a rapidly changing global environment. Nurses are educationally in tune to the proposed changes that are being made, yet sensitive enough to address the needs of individuals affected by these changes. In a global community, nurses advocate for the individual. I believe at the heart of nursing is the provision of care. Caring is the fundamental tenet behind all that we do and say in our relationships with patients. Caring is a value I possess. Caring, is also a trait that must be nurtured and cultivated in all nurses to be therapeutic and of value to patients. Nurse educators facilitate students development of effective care. I believe the profession of nursing is an expression of kindness and connectivity between human beings that creates change in community. The commitment to partner with an individual, family, or population during a time of need and assist them towards healing is what true community is all about. Nurse educators partner with students to further change. I believe nurses facilitate both the restoration andShow MoreRelatedMy Philosophy Of Nursing Education1333 Words   |  6 PagesMy philosophy of nursing education develops out of my philosophy of nursing. They are woven together as I am both a nurse and educator. I don t desire to be one without the other; and, I trust the two together are much more grounded than either one alone. My philosophy of nursing is based off the four concepts of nursing. The four concepts of nursing are person, health, nursing, and environment. My own philosophy of teaching is a result of numerous impacts including background, guideline, a mergingRead More My Personal Philosophy Of Nursing Education1075 Words   |  5 PagesMy Personal Philosophy of Nursing Education My personal philosophy of nursing education is a work in progress as I continue to grow as a nurse, and educator and as a scholar of nursing education. I am not new to the role of nurse or educator, but newer to the role of nursing educator. Nursing is the healing energy of caring, embodied in knowledge and skills. Each person is a unique combination of cognitive and physical energy blended together and infused by spiritual energy. Spiritual energy providesRead MoreNursing : Health Cooperation, And Personal Philosophy Of Nursing Care1339 Words   |  6 PagesPersonal: Philosophy of Nursing Care Introduction Nursing philosophies are used by many institutions and places of employment. It is important that student nurses and nurses read and gain knowledge from their facilities nursing philosophy. Philosophies give the nurse a guideline of how their facility defines the aspects of nursing and what is expected of them as nurses of that facility. It is essential for nurses to go back after they have graduated from nursing school and reread the nursing philosophyRead MoreHistory of Education and Philosophy of Nurse Education1416 Words   |  6 PagesHistory and Philosophy of Nurse Education Amy Allin Capella University Abstract Each educator brings to the academic arena their own personal nursing philosophy that is based on experience and is historic in nature. By studying the history of nursing, the educator is able to guide the student through their education process. As an educator the nurse becomes an extension of one’s own personal philosophy. Nursing theory serves as the foundation on which to develop a personal philosophy and characterizesRead MoreMy Personal Philosophy Of Nursing949 Words   |  4 PagesMy Personal Philosophy of Nursing My inspiration to pursue a career in Nursing began at a young age, after reading the biography of Florence Nightingale. I was in middle school, and intrigued at her courage, and dedication to care for the sick. As I entered college, and into a formal nursing education program, I still viewed nursing as, the care provided to another in need. Without my knowing, I was developing a philosophy of nursing for myself. As the years passed, I began to realize that nursingRead MoreMy Personal Philosophy Of Nursing1330 Words   |  6 PagesMy Personal Philosophy of Nursing The purpose of this essay is to depict the personal philosophy of nursing and any future aspirations I have acquired in my first semester of nursing school. Before I can create my own philosophy of nursing, I must first understand and define what philosophy is and how it relates to nursing. According to  the Oxford Dictionary, philosophy is â€Å"the study of the fundamental nature of knowledge, reality, and existence, especially when considered as an academic discipline†Read MoreHigher Education Faculty Teaching Philosophy845 Words   |  4 PagesHigher Education Faculty Teaching Philosophy Introduction Many higher institutions have a statement of philosophies of their own derived from their pioneer or parent institutions or organizations (Higgins Leonora, 2009). The Catholic University of America School of Nursing has its pioneer group that is the Catholic Church. Therefore, every value, virtue, norm, composition and beliefs are all originated from the Catholic Church and are thus modified to fit its environmentRead MorePersonal Philosophy of Nursing Essay621 Words   |  3 PagesRunning head: Philosophy of Nursing Philosophy of Nursing Nancho DeChirico University of Phoenix Philosophy of Nursing For as long as I can remember, nursing was a profession that I longed to be a part of because nurses represented the very essence of caring and compassion. After realizing my dream, I found myself working in a Neonatal Intensive Care Unit (NICU) where I developed a personal philosophy and core set of values regarding nursing. â€Å"Philosophies of nursing are statementsRead MoreMy Personal Philosophy Of Nursing1081 Words   |  5 PagesRunning head: PERSONAL PHILOSOPHY OF NURSING 1 PERSONAL PHILOSOPHY OF NURSING 6 Personal Philosophy of Nursing Caroline Thiongo BSN V Millers College of Nursing Abstract This paper explores my personal nursing philosophy that I will convey in my career of nursing. It is my belief that nursing is a commitment to public service and a desire to help those in need. Nursing is a discipline of knowledge acquired both through formal education and through life experiences. The sum of these parts continuesRead MoreMy Personal Philosophy Of Nursing Essay1028 Words   |  5 Pagesinterest in nursing the main reason is the superior nursing care to my family member offered by the US hospitals. My personal philosophy is universal provision of health-care despite one’s background. As a nurse, one is responsible to offer professional services in any environment. I defined person, environment, health and nursing. My four personal philosophy concepts include competence, accountability, compassion and caring. Nursing philosophy is important because of practice, education, administration